Brain Iron Distribution after Multiple Doses of Ultra-small Superparamagnetic Iron Oxide Particles in Rats.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Comparative medicine

• Publication date

  2018-04-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 29663939PMCID PMC5897970
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of an fMRI USPIO‐based assay in healthy human volunteers

  2017cited by this paper
• In vivo Delivery, Pharmacokinetics, Biodistribution and Toxicity of Iron Oxide Nanoparticles

  2016cited by this paper
• Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors

  2015cited by this paper
• Multiple sclerosis lesion geometry in quantitative susceptibility mapping (QSM) and phase imaging

  2015cited by this paper
• In vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticles.

  2015cited by this paper
• Translocation across the Air–Blood Tissue Barrier

  2015cited by this paper
• Pediatric choroid plexus hemosiderosis

  2015cited by this paper
• Whole-agent selectivity within the macaque face-processing system

  2015cited by this paper
• Algorithm for fast monoexponential fitting based on Auto‐Regression on Linear Operations (ARLO) of data

  2015cited by this paper
• Vascular Imaging With Ferumoxytol as a Contrast Agent.

  2015cited by this paper
• Iron entry in neurons and astrocytes: a link with synaptic activity

  2015cited by this paper
• Quantitative Susceptibility Mapping at 3 T and 1.5 T: Evaluation of Consistency and Reproducibility

  2015cited by this paper
• Face Patch Resting State Networks Link Face Processing to Social Cognition

  2015cited by this paper
• Quantitative assessment of microvasculopathy in arcAβ mice with USPIO-enhanced gradient echo MRI

  2015cited by this paper
• Simultaneous Phase Unwrapping and Removal of Chemical Shift (SPURS) Using Graph Cuts: Application in Quantitative Susceptibility Mapping

  2015cited by this paper
• Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker

  2014cited by this paper
• Uptake and Metabolism of Iron Oxide Nanoparticles in Brain Cells

  2014cited by this paper
• Layer-dependent BOLD and CBV-weighted fMRI responses in the rat olfactory bulb

  2014cited by this paper
• Waxholm Space atlas of the Sprague Dawley rat brain

  2014cited by this paper
• Transfusional iron overload presenting as choroid plexus hemosiderosis.

  2013cited by this paper
• Nonlinear formulation of the magnetic field to source relationship for robust quantitative susceptibility mapping

  2013cited by this paper
• High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle

  2013cited by this paper
• Cerebral blood volume MRI with intravascular superparamagnetic iron oxide nanoparticles

  2013cited by this paper
• Ferumoxytol enhanced resting state fMRI and relative cerebral blood volume mapping in normal human brain

  2013cited by this paper
• Quantitative Susceptibility Mapping: Magnetic Resonance Imaging of Tissue Magnetism

  2013cited by this paper
• Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: Application to determine iron content in deep gray matter structures

  2013cited by this paper
• Cell trafficking through the choroid plexus

  2012cited by this paper
• Chelators in the Treatment of Iron Accumulation in Parkinson's Disease

  2012cited by this paper
• Reducing the object orientation dependence of susceptibility effects in gradient echo MRI through quantitative susceptibility mapping

  2012cited by this paper
• Contrast-enhanced functional blood volume imaging (CE-fBVI): Enhanced sensitivity for brain activation in humans using the ultrasmall superparamagnetic iron oxide agent ferumoxytol

  2012cited by this paper
• Morphology enabled dipole inversion for quantitative susceptibility mapping using structural consistency between the magnitude image and the susceptibility map

  2012cited by this paper
• Nanoparticles in gene therapy principles, prospects, and challenges.

  2011cited by this paper
• A pilot trial of deferiprone for neurodegeneration with brain iron accumulation

  2011cited by this paper
• Self-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomas.

  2011cited by this paper
• Quantitative susceptibility mapping of human brain reflects spatial variation in tissue composition

  2011cited by this paper
• Long term in vivo biotransformation of iron oxide nanoparticles.

  2011cited by this paper
• Quantitative susceptibility map reconstruction from MR phase data using bayesian regularization: Validation and application to brain imaging

  2010cited by this paper
• Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION)

  2010cited by this paper
• Rapid Pharmacokinetic and Biodistribution Studies Using Cholorotoxin-Conjugated Iron Oxide Nanoparticles: A Novel Non-Radioactive Method

  2010cited by this paper
• Nonlinear Regularization for Per Voxel Estimation of Magnetic Susceptibility Distributions From MRI Field Maps

  2010cited by this paper
• FDA report: Ferumoxytol for intravenous iron therapy in adult patients with chronic kidney disease

  2010cited by this paper
• Susceptibility mapping in the human brain using threshold‐based k‐space division

  2010cited by this paper
• Brain iron homeostasis, the choroid plexus, and localization of iron transport proteins

  2009cited by this paper
• Iron oxide particles for atheroma imaging.

  2009cited by this paper
• Inhaled Fluorescent Magnetic Nanoparticles Induced Extramedullary Hematopoiesis in the Spleen of Mice

  2009cited by this paper
• Magnetic susceptibility mapping of brain tissue in vivo using MRI phase data

  2009cited by this paper
• Physicochemical properties of ferumoxytol, a new intravenous iron preparation

  2009cited by this paper
• Calculation of susceptibility through multiple orientation sampling (COSMOS): A method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI

  2009cited by this paper
• Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats.

  2008cited by this paper
• Quantitative MR susceptibility mapping using piece‐wise constant regularized inversion of the magnetic field

  2008cited by this paper
• Magnetic nanoparticles in MR imaging and drug delivery.

  2008cited by this paper
• R2 and R2* mapping for sensing cell-bound superparamagnetic nanoparticles: in vitro and murine in vivo testing.

  2007cited by this paper
• Selective iron chelation in Friedreich ataxia: biologic and clinical implications.

  2007cited by this paper
• Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents

  2007cited by this paper
• Toxicity and tissue distribution of magnetic nanoparticles in mice.

  2006cited by this paper
• Preclinical Safety and Pharmacokinetic Profile of Ferumoxtran-10, an Ultrasmall Superparamagnetic Iron Oxide Magnetic Resonance Contrast Agent

  2006cited by this paper
• Ultrasmall Supraparamagnetic Iron Oxide-Enhanced Magnetic Resonance Imaging of Antigen-Induced Arthritis: A Comparative Study Between SHU 555 C, Ferumoxtran-10, and Ferumoxytol

  2006cited by this paper
• The choroid plexus-cerebrospinal fluid system: from development to aging.

  2005cited by this paper
• First‐pass contrast‐enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)‐based blood pool agent

  2005cited by this paper
• Dosage Determination of Ultrasmall Particles of Iron Oxide for the Delineation of Microvasculature in the Wistar Rat Brain

  2005cited by this paper
• Structure, chemistry, and pharmacokinetics of intravenous iron agents.

  2004cited by this paper
• The Metabolism of Neuronal Iron and Its Pathogenic Role in Neurological Disease: Review

  2004cited by this paper
• Manganese distribution across the blood-brain barrier. II. Manganese efflux from the brain does not appear to be carrier mediated.

  2003cited by this paper
• MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice.

  2003cited by this paper
• Repeated fMRI Using Iron Oxide Contrast Agent in Awake, Behaving Macaques at 3 Tesla

  2002cited by this paper
• Application of the static dephasing regime theory to superparamagnetic iron‐oxide loaded cells

  2002cited by this paper
• MR choroid plexus sign of iron overload

  2000cited by this paper
• Pharmacokinetic and hemodynamic safety of two superparamagnetic agents, Endorem and Sinerem, in cirrhotic rats.

  1998cited by this paper
• Transport of Iron in the Blood‐Brain‐Cerebrospinal Fluid System

  1997cited by this paper
• Guide for the Care and Use of Laboratory Animals

  1996cited by this paper
• Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

  1992cited by this paper
• Transverse relaxivity of particulate MRI contrast media: From theories to experiments

  1991cited by this paper
• The NMR phased array

  1990cited by this paper
• Age-associated lesions in barrier-reared male Sprague-Dawley rats: A comparison between hap: (SD) and CrI:COBS[R]CD[R](SD) stocks

  1982cited by this paper
• Age‐Associated Lesions in Barrier‐Reared Male Sprague‐Dawley Rats: A Comparison Between Hap: (SD) and Crl:COBS[R]CD[R] (SD)Stocks 1, , 6

  1982cited by this paper

• Relationship between cognitive impairment and hippocampal iron overload: A quantitative susceptibility mapping study of a rat model

  2025cites this paper
• Microvascular and astrocytic responses to repeated magnetic resonance-guided focused ultrasound.

  2025cites this paper
• Quercetin attenuates neurotoxicity induced by iron oxide nanoparticles

  2021cites this paper
• Detection of glioblastoma multiforme using quantitative molecular magnetic resonance imaging based on 5-aminolevulinic acid: in vitro and in vivo studies

  2021cites this paper
• Minimal specifications for non-human primate MRI: Challenges in standardizing and harmonizing data collection

  2020cites this paper
• Tracking Neural Progenitor Cell Migration in the Rodent Brain Using Magnetic Resonance Imaging

  2019cites this paper
• The negative effect of magnetic nanoparticles with ascorbic acid on peritoneal macrophages

  2019cites this paper
• Neurotoxicity of green- synthesized magnetic iron oxide nanoparticles in different brain areas of Wistar rats.

  2019cites this paper